Worldwide Review of Restrictions Placed Upon People With HIV/AIDS

December 1992 in “ Reviews in Medical Virology ”

Dayanath Jayasuriya

Studysummary The review concluded that restrictions on people with HIV/AIDS often violated their rights without proven effectiveness in stopping the virus, highlighting education as the best control method.

Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer ·

Read the full study on onlinelibrary.wiley.com →

Discuss this study in the Community →

Similar research 5

Dermatologic Manifestations of Human Immunodeficiency Virus Infection Mayo Clinic Proceedings · 1992
Non-Infective Mucocutaneous Presentations of Human Immunodeficiency Virus Infection Australasian Journal of Dermatology · 1997
Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretroviral Therapy: A Review of Prevalence NEWPORT INTERNATIONAL JOURNAL OF SCIENTIFIC AND EXPERIMENTAL SCIENCES · 2023
HIV/AIDS and Dermatological Findings at a Glance: What Has Changed in the ART Era Current HIV Research · 2026
The Impact of HIV-Related Diseases on Pigmented Skin Types British Journal of Dermatology · 2013

Related Community Posts Join

6 / 1000+ results

community European Medecine Agency (EMA) review of Finasteride and Dutasteride

in Finasteride/Dutasteride 37 upvotes 1 year ago

Concerns about a potential ban on finasteride and dutasteride due to side effects, with users advocating for continued access and informed choice. Alternative treatments like pyrilutamide are also mentioned.

community The EU has Finasteride and Dutasteride under review at risk of getting banned.

in Finasteride/Dutasteride 159 upvotes 1 year ago

Finasteride and Dutasteride are under review in the EU due to concerns about side effects like depression, but they are unlikely to be banned. Access to these medications varies, with easier availability in the UK compared to some EU countries.

community CMDh final position just arrived. Finasteride and Dutasteride to remain accessible in the EU

in Finasteride/Dutasteride 168 upvotes 1 year ago

Finasteride and Dutasteride will remain accessible in the EU despite objections from France and Belgium. Users discuss the ease of obtaining these medications in different countries and express relief and support for the EU's decision.

community Dermatologist says finasteride is no longer prescribed after apothecaries warning (Austria)

65 upvotes 9 months ago

In Austria, finasteride prescriptions are restricted due to suicide risk concerns, with new prescriptions only for current users. Alternatives like topical finasteride, dutasteride, and online purchases face legal challenges.

community EMA is re-examining Winlevi (clascoterone at lower concentration)

8 upvotes 1 year ago

Clascoterone in Winlevi, a topical AR antagonist, is being re-examined due to concerns about HPA axis suppression in adolescents, but it's unlikely to be banned for adult use in androgenetic alopecia (AGA). The European Medicines Agency recommended refusing Winlevi for acne vulgaris, but this may not affect Breezula's approval for AGA.

community New human study (Aug 2026) directly tested whether RU58841 stays local - it doesn't

8 upvotes 3 weeks ago

RU58841 is absorbed systemically in humans, contradicting claims it stays local, but no harm is proven. Alternatives like CB-03-01 or KX-826, especially with finasteride, are suggested for safety.